{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:08Z","timestamp":1792782908110,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"VHS Medical Center Research Grant from the Republic of Korea","award":["VHSMC22027"],"award-info":[{"award-number":["VHSMC22027"]}],"id":[{"id":"https:\/\/ror.org\/00xhz2q61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10557-026-07895-2","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:25:23Z","timestamp":1779956723000},"page":"1839-1847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Citrated Kaolin Reaction Time on Thromboelastography 6s Identifies Bleeding-Prone Phenotypes in Older Adults with Atrial Fibrillation Receiving Direct Oral Anticoagulant Therapy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-0311","authenticated-orcid":false,"given":"Jin Kyung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7567-9196","authenticated-orcid":false,"given":"Su Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-623X","authenticated-orcid":false,"given":"Sung Joo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-9395","authenticated-orcid":false,"given":"Chee Hae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1622-272X","authenticated-orcid":false,"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"7895_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jacasi.2022.07.008","volume":"2","author":"K Okumura","year":"2022","unstructured":"Okumura K, Yamashita T, Akao M, et al. Oral anticoagulants in very elderly nonvalvular atrial fibrillation patients with high bleeding risks: ANAFIE registry. JACC Asia. 2022;2:720\u201333. https:\/\/doi.org\/10.1016\/j.jacasi.2022.07.008.","journal-title":"JACC Asia"},{"issue":"4","key":"7895_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10557-024-07589-7","volume":"39","author":"T Bang","year":"2025","unstructured":"Bang T, Lori H, Brent F, et al. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database. Cardiovasc Drugs Ther. 2025;39(4):823\u201335. https:\/\/doi.org\/10.1007\/s10557-024-07589-7.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7895_CR3","doi-asserted-by":"publisher","first-page":"eS44","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, et al. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:eS44\u201388. https:\/\/doi.org\/10.1378\/chest.11-2292.","journal-title":"Chest"},{"key":"7895_CR4","doi-asserted-by":"publisher","unstructured":"Liang X, Liu S, Ji L. et at. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2024;39(6):1375\u201386. https:\/\/doi.org\/10.1007\/s10557-024-07616-7","DOI":"10.1007\/s10557-024-07616-7"},{"key":"7895_CR5","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"7895_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2024;149:e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"key":"7895_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. Lancet. 2014;383:955\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0.","journal-title":"Lancet"},{"key":"7895_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jth.14001","volume":"16","author":"S Testa","year":"2018","unstructured":"Testa S, Paoletti O, Legnani C, et al. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost. 2018;16:842\u20138. https:\/\/doi.org\/10.1111\/jth.14001.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"7895_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10557-023-07537-x","volume":"39","author":"N Mohamed","year":"2025","unstructured":"Mohamed N, Muhammad S, Ahmed E, et al. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis. Cardiovasc Drugs Ther. 2025;39(3):643\u201360. https:\/\/doi.org\/10.1007\/s10557-023-07537-x.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7895_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ajh.23599","volume":"89","author":"D Whiting","year":"2014","unstructured":"Whiting D, DiNardo JA. TEG and ROTEM: Technology and clinical applications. Am J Hematol. 2014;89:228\u201332. https:\/\/doi.org\/10.1002\/ajh.23599.","journal-title":"Am J Hematol"},{"key":"7895_CR11","doi-asserted-by":"publisher","unstructured":"Sankarankutty A, Nascimento B, Teodoro da Luz L, et al. TEG\u00ae\u00ae in trauma: Similar test but different results? World J Emerg Surg. 2012;7:S3. https:\/\/doi.org\/10.1186\/1749-7922-7-S1-S3.","DOI":"10.1186\/1749-7922-7-S1-S3"},{"key":"7895_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5858\/arpa.2014-0170-OA","volume":"139","author":"JD Dias","year":"2015","unstructured":"Dias JD, Norem K, Doorneweerd DD, et al. Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med. 2015;139:665\u201373. https:\/\/doi.org\/10.5858\/arpa.2014-0170-OA.","journal-title":"Arch Pathol Lab Med"},{"key":"7895_CR13","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1055\/a-1692-1415","volume":"5","author":"R Artang","year":"2021","unstructured":"Artang R, Dias JD, Walsh M, et al. Measurement of anticoagulation in patients on dabigatran, Rivaroxaban, and apixaban therapy by novel automated thrombelastography. TH Open. 2021;5:e570\u20136. https:\/\/doi.org\/10.1055\/a-1692-1415.","journal-title":"TH Open"},{"key":"7895_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11239-017-1477-1","volume":"43","author":"KP Bliden","year":"2017","unstructured":"Bliden KP, Chaudhary R, Mohammed N, et al. Determination of non-vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017;43:437\u201345. https:\/\/doi.org\/10.1007\/s11239-017-1477-1.","journal-title":"J Thromb Thrombolysis"},{"key":"7895_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/09537104.2016.1153617","volume":"27","author":"PA Gurbel","year":"2016","unstructured":"Gurbel PA, Bliden KP, Tantry US, et al. First report of the point-of-care TEG: A technical validation study of the TEG-6S system. Platelets. 2016;27:642\u20139. https:\/\/doi.org\/10.3109\/09537104.2016.1153617.","journal-title":"Platelets"},{"key":"7895_CR16","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1097\/HS9.0000000000000286","volume":"3","author":"F Rodeghiero","year":"2019","unstructured":"Rodeghiero F, Pabinger I, Ragni M, et al. Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: An EHA consensus report. Hemasphere. 2019;3:e286. https:\/\/doi.org\/10.1097\/HS9.0000000000000286.","journal-title":"Hemasphere"},{"key":"7895_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07741-x","author":"S Sufyan","year":"2025","unstructured":"Sufyan S, Minahil I, Mariam S, et al. Factor XIa Inhibitors Versus Direct Oral Anticoagulants for Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Cardiovasc Drugs Ther. 2025. https:\/\/doi.org\/10.1007\/s10557-025-07741-x. Epub ahead of print.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"7895_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/rth2.12206","volume":"3","author":"A Ramin","year":"2019","unstructured":"Ramin A, Maren A, Jorn DN. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers. Res Pract Thromb Haemost. 2019;3(3):391\u20136. https:\/\/doi.org\/10.1002\/rth2.12206.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"7895_CR19","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1055\/a-1692-1415","volume":"5","author":"A Ramin","year":"2021","unstructured":"Ramin A, Joao DD, Mark W, et al. Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography. TH Open. 2021;5(4):e570\u20136. https:\/\/doi.org\/10.1055\/a-1692-1415.","journal-title":"TH Open"},{"key":"7895_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-0042-1757545","volume":"49","author":"J Hartmann","year":"2023","unstructured":"Hartmann J, Curzen N. Modified thromboelastography for peri-interventional assessment of platelet function in cardiology patients: A narrative review. Semin Thromb Hemost. 2023;49:192\u2013200. https:\/\/doi.org\/10.1055\/s-0042-1757545.","journal-title":"Semin Thromb Hemost"},{"key":"7895_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1055\/a-1346-3178","volume":"121","author":"A S\u0142omka","year":"2021","unstructured":"S\u0142omka A, Kowalewski M, \u017bekanowska E. Hemostasis in coronavirus disease 2019-lesson from viscoelastic methods: A systematic review. Thromb Haemost. 2021;121:1181\u201392. https:\/\/doi.org\/10.1055\/a-1346-3178.","journal-title":"Thromb Haemost"},{"key":"7895_CR22","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.3390\/jcm11133652","volume":"11","author":"O Xu","year":"2022","unstructured":"Xu O, Hartmann J, Tang YD, et al. The use of thromboelastography in percutaneous coronary intervention and acute coronary syndrome in East Asia: A systematic literature review. J Clin Med. 2022;11:3652. https:\/\/doi.org\/10.3390\/jcm11133652.","journal-title":"J Clin Med"},{"key":"7895_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/rth2.12206","volume":"3","author":"R Artang","year":"2019","unstructured":"Artang R, Anderson M, Nielsen JD. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers. Res Pract Thromb Haemost. 2019;3:391\u20136. https:\/\/doi.org\/10.1002\/rth2.12206.","journal-title":"Res Pract Thromb Haemost"},{"key":"7895_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11886-018-0975-x","volume":"20","author":"F Shaikh","year":"2018","unstructured":"Shaikh F, Pasch LB, Newton PJ, et al. Addressing multimorbidity and polypharmacy in individuals with atrial fibrillation. Curr Cardiol Rep. 2018;20:32. https:\/\/doi.org\/10.1007\/s11886-018-0975-x.","journal-title":"Curr Cardiol Rep"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07895-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:29:05Z","timestamp":1789522145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["7895"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07895-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB) of the participating institution (IRB No: BOHUN 2023-01-007-001) and conformed to the principles of the Declaration of Helsinki (2024).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent before enrollment.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}